MEGIN Spotlights

Dive into MEGIN Spotlights for engaging conversations with thought leaders, partners, customers, and caregivers as they offer unique insights and experiences with MEG.

Explore Spotlights

Dr. Malik discussing how MEG has helped in delineate frontal lobe epilepsy

In this episode, Dr. Saleem Malik discusses how MEG has helped in delineate frontal lobe epilepsy and other areas of epileptic foci.

Dr. Fernando Maestu, Center for Biomedical Technology of Madrid

In this Spotlight, Dr. Fernando Maestu from the Center for Biomedical Technology of Madrid discusses how the Lab uses MEG data to support Alzheimer’s Disease.

Epilepsy patient’s incredible journey now seizure free after brain surgery

An incredible journey of a teenager who is now able to live free of epileptic seizures since brain surgery. This was achieved through a combination of methods and tools, including Magnetoencephalography (MEG), a functional brain imaging technology.

Dr. Saleem Malik, Fort Worth, Texas USA

An insightful discussion how using neuroimaging tools including Magnetoencephalography (MEG) helps patients with refractory epilepsy.

Sven Braeutigam, Oxford Centre for Human Brain Activity (OHBA)

We are excited to have Sven Braeutigam, the Senior Researcher and MEG Physicist of the Oxford Centre for Human Brain Activity as our guest for this Spotlight episode.

Dr. James Wheless, Chief Neurologist at Le Bonheur Children’s Hospital

We are excited to have Dr James Wheless as our guest, who is the Chief Neurologist and Co-director of the Neuroscience Institute at Le Bonheur Children’s Hospital in Memphis.

Patricia Kuhl, Co-Director of the Institute for Learning and Brain Science (I-LABS)

I-LABS is a center dedicated to discovering the fundamental principles of human learning, with a special emphasis on early learning and brain development.

Dr. Stephan Rampp

MEGIN Spotlight invited Dr Stefan Rampp from University Hospital in Erlangen to share his knowledge and experience using Magnetoencephalography (MEG) in treatment of patients diagnosed with neurological disorders.